Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 6,473.50
-45.00 (-0.69%)
Nov 18, 2025, 3:29 PM IST
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 1.73 trillion as of November 18, 2025. Its market cap has increased by 12.32% in one year.
Market Cap
1.73T
Enterprise Value
1.70T
Revenue
100.29B
Ranking
n/a
PE Ratio
69.65
Stock Price
6,473.50
Market Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 1.73T, an increase of 84,913.18%. That is a compound annual growth rate of 34.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 1.72T | 6.14% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | 1.02T | 108.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.23T |
| Cipla | 1.24T |
| Apollo Hospitals Enterprise | 1.07T |
| Zydus Lifesciences | 940.58B |
| Mankind Pharma | 935.76B |
| Aurobindo Pharma | 718.39B |
| Fortis Healthcare | 707.92B |
| Alkem Laboratories | 684.27B |